Ajit K Saxena Selected Research

boswellic acid

12/2013	Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059.
6/2013	NF-κB down-regulation and PARP cleavage by novel 3-α-butyryloxy-β-boswellic acid results in cancer cell specific apoptosis and in vivo tumor regression.
1/2012	Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs.
1/2011	A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ajit K Saxena Research Topics

Disease

30	Neoplasms (Cancer) 01/2017 - 01/2007
6	Leukemia 01/2015 - 04/2008
4	Ascites 09/2016 - 01/2007
3	Colonic Neoplasms (Colon Cancer) 03/2016 - 10/2010
3	Lung Neoplasms (Lung Cancer) 11/2014 - 10/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 10/2010
2	Lymphoid Leukemia 01/2015 - 01/2015
1	Necrosis 01/2015
1	Neural Tube Defects (Exencephaly) 01/2015
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2014
1	Retinoblastoma (Glioblastoma, Retinal) 12/2013
1	Neuroblastoma 10/2010
1	Carcinoma (Carcinomatosis) 01/2007

Drug/Important Bio-Agent (IBA)

4	lissamine rhodamine B (sulforhodamine B)IBA 01/2015 - 10/2010
4	Coloring Agents (Dyes)IBA 11/2014 - 10/2010
4	boswellic acidIBA 12/2013 - 01/2011
3	TubulinIBA 01/2017 - 06/2016
3	TriazolesIBA 01/2017 - 11/2015
3	Colchicine FDA LinkGeneric 11/2016 - 05/2015
2	IsatinIBA 01/2017 - 11/2015
2	Gemcitabine FDA Link 09/2016 - 08/2014
2	Betulinic AcidIBA 05/2016 - 05/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 01/2007
2	AcidsIBA 06/2013 - 01/2011
2	Podophyllotoxin (Condylox)FDA LinkGeneric 06/2011 - 09/2008
1	coumarinIBA 01/2017
1	methoxypolyethyleneglycol- poly(lactic- co- glycolic acid)IBA 09/2016
1	Cyclin D1IBA 05/2016
1	acetamideIBA 03/2016
1	CurcuminIBA 11/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 01/2015
1	Plant ExtractsIBA 01/2015
1	Sepharose (Agarose)IBA 01/2015
1	Caspase 3 (Caspase-3)IBA 11/2014
1	Benzene (Benzole)IBA 10/2014
1	HexanesIBA 10/2014
1	AcetoneIBA 10/2014
1	Cytidine DeaminaseIBA 08/2014
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 08/2014
1	NucleosidesIBA 08/2014
1	artemisinin (artemisinine)IBA 01/2014
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	Cyclin EIBA 12/2013
1	Cell Cycle ProteinsIBA 12/2013
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	Norisoprenoids (Irones)IBA 11/2013
1	ChalconesIBA 11/2013
1	combretastatinIBA 03/2013
1	indoleIBA 03/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	bakuchiolIBA 03/2012
1	LactonesIBA 08/2011
1	partheninIBA 08/2011
1	NF-kappa B (NF-kB)IBA 08/2011
1	KetonesIBA 08/2011
1	Methanol (Carbinol)IBA 10/2010
1	EstersIBA 10/2010
1	AmidesIBA 10/2010
1	XanthenesIBA 10/2009
1	Volatile Oils (Essential Oils)IBA 05/2009
1	LignansIBA 12/2008
1	matairesinolIBA 12/2008
1	Biological ProductsIBA 04/2008
1	Pharmaceutical PreparationsIBA 01/2007
1	RNA (Ribonucleic Acid)IBA 01/2007

Therapy/Procedure

3	Therapeutics 03/2016 - 09/2008
1	Drug Therapy (Chemotherapy) 08/2014
1	Chemoprevention 09/2008